Ongoing Lung Decline With Age Intensified Response
for Age-Related Lung Function Decline
1 location in Los Angeles
Sponsor: Cedars-Sinai Medical Center
Sex: All·Age: 60+·Accepts healthy volunteers
Code: NCT07676435·Phase 2·Recruiting·Listed Jun 2026
Clinical Trials at Cedars-Sinai Medical Center
As of August 2026, 216 paid clinical trials are recruiting at Cedars-Sinai Medical Center, located at 8700 BEVERLY BLVD, LOS ANGELES, CA 90048, phone (323) 866-8600 in Los Angeles, California. Active studies at this site cover conditions such as Breast Cancer, Colorectal Cancer and Prostate Cancer. Compensation typically covers time, travel, and study visits — most studies also offer study-related medical care at no cost to participants.
Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: .
Filter results
Filter results
Newly added in Los Angeles
Posted to ClinicalTrials.gov within the last 60 days — these studies are just starting to recruit.
217 clinical trials at Cedars-Sinai Medical Center
·Clear filters· Get a weekly email when new trials open in Los Angeles, CA.
Phase 2/3 Adaptive Study of VX-147 in Adult and Pediatric Participants With APOL1-Mediated Proteinuric Kidney Disease
for Proteinuric Kidney Disease
Sites in Los Angeles, Torrance +163 more locations
Sponsor: Vertex Pharmaceuticals Incorporated
Sex: All·Age: 10 - 65
Code: NCT05312879·Phase 2, Phase 3·Recruiting·Listed Apr 2022
A Study to Investigate Ronde-cel Versus Investigator's Choice CD19 CAR T-Cell Therapy
for Large B-cell Lymphoma
Sites in Los Angeles, Orange +34 more locations
Sponsor: Lyell Immunopharma, Inc.
Sex: All·Age: 18+
Code: NCT07188558·Phase 3·Recruiting·Listed Sep 2025
Combined Dose-Finding and CV Outcomes Study With CSL300 (Clazakizumab) in Adult Subjects With ESKD Undergoing Dialysis (POSIBIL6ESKD)
for End Stage Kidney Disease
Drug: Clazakizumab
Sites in Los Angeles, Tarzana +146 more locations
Sponsor: CSL Behring
Sex: All·Age: 18+
Code: NCT05485961·Phase 2, Phase 3·Recruiting·Listed Aug 2022
A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer
for Carcinoma, Non-Small-Cell Lung
Drug: LY3537982
Sites in Los Angeles, Walnut Creek +86 more locations
Sponsor: Eli Lilly and Company
Sex: All·Age: 18+
Code: NCT06119581·Phase 3·Recruiting·Listed Nov 2023
Phase 3 Study of RLY-2608 + Fulvestrant vs Capivasertib + Fulvestrant as Treatment for Locally Advanced or Metastatic PIK3CA-mutant HR+/HER2- Breast Cancer
for PIK3CA Mutation
Sites in Los Angeles, Beverly Hills +50 more locations
Sponsor: Relay Therapeutics, Inc.
Sex: All·Age: 18+
Code: NCT06982521·Phase 3·Recruiting·Listed May 2025
Studies to Assess Ziftomenib in Combination With Ven+Aza or 7+3 in Patients With Untreated NPM1-m or KMT2A-r AML
for Acute Myeloid Leukemia (AML)
Sites in Los Angeles, Orange +40 more locations
Sponsor: Kura Oncology, Inc.
Sex: All·Age: 18+
Code: NCT07007312·Phase 3·Recruiting·Listed Jun 2025
Consolidation of First-Line MRD+ Remission With Cema-cel in Patients With LBCL
for Large B-cell Lymphoma
Sites in Los Angeles, Duarte +59 more locations
Sponsor: Allogene Therapeutics
Sex: All·Age: 18+
Code: NCT06500273·Phase 2·Recruiting·Listed Jul 2024
A Study Evaluating the Safety and Efficacy of Targeted Therapies in Subpopulations of Patients With Metastatic Colorectal Cancer (INTRINSIC)
for Metastatic Colorectal Cancer
Sites in Los Angeles, Duarte +18 more locations
Sponsor: Hoffmann-La Roche
Sex: All·Age: 18+
Code: NCT04929223·Phase 1·Recruiting·Listed Jun 2021
Study Assessing Activity of Intravenous (IV) Etentamig Monotherapy Versus Standard Available Therapies in Adult Participants With Relapsed or Refractory Multiple Myeloma
for Multiple Myeloma
Drug: Etentamig
Sites in Los Angeles, Fullerton +33 more locations
Sponsor: AbbVie
Sex: All·Age: 18+
Code: NCT06158841·Phase 3·Recruiting·Listed Dec 2023
A Study to Evaluate Zilovertamab Vedotin (MK-2140) Combination With Rituximab Plus Cyclophosphamide, Doxorubicin, and Prednisone (R-CHP) Versus Rituximab Plus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone (R-CHOP) in Participants With Previously Untreated DLBCL (MK-2140-010)
for Diffuse Large B-Cell Lymphoma
Drug: Rituximab
Sites in Los Angeles, Long Beach +43 more locations
Sponsor: Merck Sharp & Dohme LLC
Sex: All·Age: 18+
Code: NCT06717347·Phase 3·Recruiting·Listed Dec 2024
A Study of Vedolizumab With Tofacitinib in Adults With Ulcerative Colitis (UC)
for Ulcerative Colitis
Drug: Tofacitinib
Sites in Los Angeles, Newport Beach +35 more locations
Sponsor: Takeda
Sex: All·Age: 18 - 65
Code: NCT06095128·Phase 4·Recruiting·Listed Oct 2023
A Study of Vedolizumab Intravenous (IV) and Adalimumab or Vedolizumab and Ustekinumab in Adults With Crohn's Disease
for Crohn's Disease
Drug: Ustekinumab
Sites in Los Angeles, Newport Beach +39 more locations
Sponsor: Takeda
Sex: All·Age: 18 - 70
Code: NCT06045754·Phase 4·Recruiting·Listed Sep 2023
A Clinical Study of Ifinatamab Deruxtecan (I-DXd) in People With Metastatic Prostate Cancer (MK-2400-001)
for Prostate Cancer
Sites in Los Angeles, Long Beach +47 more locations
Sponsor: Merck Sharp & Dohme LLC
Sex: Male·Age: 18+
Code: NCT06925737·Phase 3·Recruiting·Listed Apr 2025
ALLIANCE: Safety and Effectiveness of the SAPIEN X4 Transcatheter Heart Valve
for Aortic Stenosis, Severe
Sites in Los Angeles, San Francisco +17 more locations
Sponsor: Edwards Lifesciences
Sex: All·Age: All ages
Code: NCT05172960·Recruiting·Listed Dec 2021
Study of Rondecabtagene Autoleucel in Aggressive Large B-Cell Lymphoma
for Relapsed Non-Hodgkin Lymphoma
Sites in Los Angeles, Irvine +30 more locations
Sponsor: Lyell Immunopharma, Inc.
Sex: All·Age: 18+
Code: NCT05826535·Phase 1, Phase 2·Recruiting·Listed Apr 2023
DeciPHer-ILD: A Real-world Patient Registry in Group 3 Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)
for Pulmonary Hypertension Due to Lung Diseases and Hypoxia
Sites in Los Angeles, Sacramento +68 more locations
Sponsor: United Therapeutics
Sex: All·Age: 18+
Code: NCT06388421·Recruiting·Listed Apr 2024
A Long-Term Study of Elafibranor in Adult Participants With Primary Biliary Cholangitis
for Primary Biliary Cholangitis (PBC)
Drug: Elafibranor
Sites in Los Angeles, Coronado +29 more locations
Sponsor: Ipsen
Sex: All·Age: 18+
Code: NCT06016842·Phase 3·Recruiting·Listed Aug 2023
Investigation of the BrioVAD System for the Treatment of Left Ventricular Heart Failure
for Cardiovascular Diseases
Sites in Los Angeles +46 more locations
Sponsor: BrioHealth Solutions, Inc.
Sex: All·Age: 18 - 100
Code: NCT06310031·Recruiting·Listed Mar 2024
Safely Optimizing Body Weight With Mifomelatide (TCMCB07) in Patients With Newly Diagnosed Colorectal Cancer (CRC) or Pancreatic Ductal Adenocarcinoma (PDAC) Undergoing Chemotherapy
for Cancer Weight Loss
Sites in Los Angeles, Santa Monica +23 more locations
Sponsor: Endevica Bio
Sex: All·Age: 18+
Code: NCT06937177·Phase 2·Recruiting·Listed Apr 2025
Global Paradise System US Post Approval Study
for Hypertension
Sites in Los Angeles, Santa Monica +41 more locations
Sponsor: ReCor Medical, Inc.
Sex: All·Age: 18+
Code: NCT06297291·Recruiting·Listed Mar 2024
A Study of Multiple Therapies in Biomarker-selected Participants With Resectable Stages IB-III Non-small Cell Lung Cancer (NSCLC)
for Non-small Cell Lung Cancer
Sites in Los Angeles, Orange +21 more locations
Sponsor: Genentech, Inc.
Sex: All·Age: 18+
Code: NCT04302025·Phase 2·Recruiting·Listed Mar 2020
A Study Investigating Oral Ozanimod (RPC1063) in Pediatric Participants With Moderate to Severe Active Ulcerative Colitis
for Colitis, Ulcerative
Sites in Los Angeles, Loma Linda +16 more locations
Sponsor: Bristol-Myers Squibb
Sex: All·Age: 2 - 17
Code: NCT05076175·Phase 2, Phase 3·Recruiting·Listed Oct 2021
ARTIST: Aortic Regurgitation Trial Investigating Surgery Versus Trilogy™
for Aortic Regurgitation
Sites in Los Angeles, Thousand Oaks +27 more locations
Sponsor: JenaValve Technology, Inc.
Sex: All·Age: All ages
Code: NCT06608823·Recruiting·Listed Sep 2024
Study of the Long-Term Safety and Outcomes of Treating Pulmonary Embolism With the Indigo Aspiration System
for Pulmonary Embolism
Sites in Los Angeles, Long Beach +53 more locations
Sponsor: Penumbra Inc.
Sex: All·Age: 18+
Code: NCT04798261·Recruiting·Listed Mar 2021
MAGNITUDE: A Phase 3 Study of NTLA-2001 in Participants With Transthyretin Amyloidosis With Cardiomyopathy (ATTR-CM)
for Transthyretin Amyloidosis (ATTR) With Cardiomyopathy
Sites in Los Angeles, San Diego +35 more locations
Sponsor: Intellia Therapeutics
Sex: All·Age: 18 - 90
Code: NCT06128629·Phase 3·Recruiting·Listed Nov 2023
A Study of the Efficacy and Safety of DMX-200 in Patients With FSGS Who Are Receiving an ARB
for FSGS
Sites in Los Angeles, Stanford +18 more locations
Sponsor: Dimerix Bioscience Pty Ltd
Sex: All·Age: 12 - 80
Code: NCT05183646·Phase 3·Recruiting·Listed Jan 2022
Sirolimus Coated BALloon Versus Standard Balloon Angioplasty in The Treatment of Below The Knee Arterial Disease
for Arterial Disease of Legs
Sites in Los Angeles +28 more locations
Sponsor: Concept Medical Inc.
Sex: All·Age: 21+
Code: NCT06182397·Recruiting·Listed Dec 2023
PROGRESS: Management of Moderate Aortic Stenosis by Clinical Surveillance or TAVR
for Aortic Stenosis, Calcific
Sites in Los Angeles, Santa Barbara +48 more locations
Sponsor: Edwards Lifesciences
Sex: All·Age: 65+
Code: NCT04889872·Recruiting·Listed May 2021
A Phase 2 Study of VS-7375 in Patients With KRAS G12D-Mutated Pancreatic Cancer
for Pancreatic Ductal Adenocarcinoma (PDAC)
Sites in Los Angeles +23 more locations
Sponsor: Verastem, Inc.
Sex: All·Age: 18+
Code: NCT07644559·Phase 2·Recruiting·Listed Jun 2026
Study of Silevertinib With Temozolomide for the Treatment of Newly Diagnosed GBM With Unmethylated MGMT and EGFRvIII
for Glioblastoma (GBM)
Sites in Los Angeles, Palo Alto +23 more locations
Sponsor: Black Diamond Therapeutics, Inc.
Sex: All·Age: 18+
Code: NCT07326566·Phase 2·Recruiting·Listed Jan 2026
A Study of NX-5948 in Adults With CLL/SLL Previously Treated With a Bruton's Tyrosine Kinase Inhibitor and a B-cell Lymphoma-2 Inhibitor (DAYBreak CLL-201)
for Chronic Lymphocytic Leukemia (CLL)
Sites in Los Angeles, Duarte +23 more locations
Sponsor: Nurix Therapeutics, Inc.
Sex: All·Age: 18+
Code: NCT07221500·Phase 2·Recruiting·Listed Oct 2025
A Study to Learn About the Effects of Felzartamab Infusions in Adults With Kidney Transplants Who Have Late Isolated Microvascular Inflammation
for Microvascular Inflammation
Sites in Los Angeles, Orange +19 more locations
Sponsor: Biogen
Sex: All·Age: 18 - 74
Code: NCT07219043·Phase 2·Recruiting·Listed Oct 2025
Long-term Characterization of GORE® TAG® Conformable Thoracic Stent Graft With ACTIVE CONTROL System Performance
for Vascular Disease
Sites in Los Angeles, Stanford +22 more locations
Sponsor: W.L.Gore & Associates
Sex: All·Age: 18+
Code: NCT06658730·Recruiting·Listed Oct 2024
Study of COYA 302 for the Treatment of ALS
for Amyotrophic Lateral Sclerosis (ALS)
Sites in Los Angeles, San Francisco +19 more locations
Sponsor: Coya Therapeutics
Sex: All·Age: 18 - 80
Code: NCT07161999·Phase 2, Phase 3·Recruiting·Listed Sep 2025
ATLAS (AltaValve) Pivotal Trial
for Mitral Regurgitation
Sites in Los Angeles, Thousand Oaks +34 more locations
Sponsor: 4C Medical Technologies, Inc.
Sex: All·Age: 18+
Code: NCT06465745·Recruiting·Listed Jun 2024
Evaluation of the Safety and Effectiveness of ARTIA Reconstructive Tissue Matrix Breast Reconstruction (ADORA) in Adult Participants
for Breast Reconstruction
Sites in Los Angeles, Orange +15 more locations
Sponsor: AbbVie
Sex: Female·Age: 18+
Code: NCT06575192·Phase 3·Recruiting·Listed Aug 2024
A Study Observing Everyday Effectiveness and Safety of the Drug Elafibranor in Participants With Primary Biliary Cholangitis Who Are Receiving Ongoing Treatment
for Primary Biliary Cholangitis
Drug: Elafibranor
Sites in Los Angeles, Coronado +17 more locations
Sponsor: Ipsen
Sex: All·Age: All ages
Code: NCT06447168·Recruiting·Listed Jun 2024
REVEAL: A Phase 3 Study of Obudanersen (ION582) in Angelman Syndrome
for Angelman Syndrome
Sites in Los Angeles, San Diego +16 more locations
Sponsor: Ionis Pharmaceuticals, Inc.
Sex: All·Age: 2 - 50
Code: NCT06914609·Phase 3·Recruiting·Listed Apr 2025
CardiolRx in Recurrent Pericarditis (MAVERIC Phase-3)
for Recurrent Pericarditis
Sites in Los Angeles, Santa Monica +19 more locations
Sponsor: Cardiol Therapeutics Inc.
Sex: All·Age: 18+
Code: NCT06708299·Phase 3·Recruiting·Listed Nov 2024
A Study to Assess A Change in Disease Activity and Adverse Events of Intravenous Etentamig and Daratumumab (Etentamig+D) Compared to Daratumumab, Lenalidomide, and Dexamethasone (DRd) in Adult Participants With Newly Diagnosed Multiple Myeloma Not Eligible for Transplant
for Multiple Myeloma
Drug: Daratumumab
Sites in Los Angeles +16 more locations
Sponsor: AbbVie
Sex: All·Age: 18+
Code: NCT07095452·Phase 2, Phase 3·Recruiting·Listed Jul 2025
Common conditions studied in Los Angeles
- Breast Cancer (38 active studies)
- Colorectal Cancer (31 active studies)
- Prostate Cancer (27 active studies)
- Ovarian Cancer (23 active studies)
- Cancer (22 active studies)
- Heart Failure (21 active studies)
Leading research sponsors in Los Angeles
- University of California, Los Angeles
- University of Southern California
- Cedars-Sinai Medical Center
- Jonsson Comprehensive Cancer Center
- National Cancer Institute (NCI)
Frequently asked questions
How many paid clinical trials are currently recruiting in Los Angeles?
There are approximately 1,968 recruiting clinical trials in Los Angeles, California listed on ClinicalTrials.gov. The number changes weekly as new studies open and others close enrollment.
Do clinical trials in Los Angeles pay participants?
Most recruiting trials in Los Angeles compensate participants for their time, travel, and study visits. Compensation varies by sponsor, study phase, and visit requirements — the exact amount is disclosed by the study team during the informed consent process.
Who can participate in a clinical trial in Los Angeles?
Eligibility depends on the specific study. Each trial defines its own inclusion criteria (age, diagnosis, medical history, prior treatments) and exclusion criteria. Both patients with specific conditions and healthy volunteers can qualify, depending on the study design.
What conditions are most commonly studied in Los Angeles?
The most common conditions under active study in Los Angeles include Breast Cancer (38), Colorectal Cancer (31), Prostate Cancer (27), Ovarian Cancer (23), among many others. Browse the list above to explore every recruiting trial.
Are there clinical trials for healthy volunteers in Los Angeles?
Yes. Healthy-volunteer studies — often early-phase pharmacology or vaccine trials — recruit in Los Angeles on an ongoing basis. Use the "Healthy volunteers only" filter above to view trials that accept participants without the study's target condition.
How do I enroll in a clinical trial in Los Angeles?
Click any study title above to see the full study record, including eligibility criteria, visit schedule, and the study team's contact information. Reach out to the central contact or recruiting site directly — they will guide you through screening and informed consent.
Where can I take part in paid clinical trials in Los Angeles?
Recruiting research sites in Los Angeles include Cedars-Sinai Medical Center, Children's Hospital Los Angeles, University of California, Los Angeles, among others. Each site lists its open studies and contact information on the study record above — call or email the site coordinator to ask about screening for a specific protocol.
What kinds of studies are recruiting in Los Angeles right now?
The largest active categories in Los Angeles are Cancer & tumors (637), Neurology & pain (111), Cardiovascular (96). Use the filters above to narrow by therapeutic area, phase, age, or healthy-volunteer eligibility.
What is the address of Cedars-Sinai Medical Center?
Cedars-Sinai Medical Center is located at 8700 BEVERLY BLVD, LOS ANGELES, CA 90048. Use the Google Maps link in the intro above to get directions.
How do I contact Cedars-Sinai Medical Center?
You can reach Cedars-Sinai Medical Center by phone at (323) 866-8600. For questions about a specific trial, use the study coordinator contact listed on the individual study record — click any trial title above to open it.
Browse more clinical trials
Other cities in California
San Francisco, CA(1,349)San Diego, CA(758)Palo Alto, CA(652)Sacramento, CA(589)Duarte, CA(543)La Jolla, CA(532)Orange, CA(508)Stanford, CA(426)Irvine, CA(375)Long Beach, CA(204)Newport Beach, CA(186)Santa Monica, CA(185)Walnut Creek, CA(184)Oakland, CA(170)Beverly Hills, CA(169)Torrance, CA(164)Loma Linda, CA(161)Anaheim, CA(126)Santa Rosa, CA(108)Fresno, CA(106)Pasadena, CA(103)Fountain Valley, CA(97)Fullerton, CA(96)Redwood City, CA(96)Glendale, CA(94)Lancaster, CA(87)Riverside, CA(85)Fremont, CA(81)Los Alamitos, CA(78)Huntington Beach, CA(77)San Jose, CA(77)Roseville, CA(71)Santa Barbara, CA(70)Vallejo, CA(66)Modesto, CA(64)Bakersfield, CA(63)Thousand Oaks, CA(62)Northridge, CA(58)Upland, CA(58)Chula Vista, CA(57)Burbank, CA(56)Berkeley, CA(55)Oceanside, CA(51)Garden Grove, CA(49)Santa Ana, CA(49)Stockton, CA(48)Santa Clara, CA(47)Pomona, CA(46)Bellflower, CA(43)San Leandro, CA(43)Santa Maria, CA(43)Tarzana, CA(42)Davis, CA(41)Downey, CA(41)San Luis Obispo, CA(41)Arroyo Grande, CA(40)Oxnard, CA(40)San Rafael, CA(40)La Mesa, CA(38)West Hills, CA(37)